Cargando…
7,8-Dihydroxycoumarin Alleviates Synaptic Loss by Activated PI3K-Akt-CREB-BDNF Signaling in Alzheimer’s Disease Model Mice
[Image: see text] Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and is clinically characterized by the impairment of memory and cognition. Accumulation of β-amyloid (Aβ) in the brain is considered as a key process in the development of AD because it impairs the synapses’ funct...
Autores principales: | Yan, Li, Jin, Yufan, Pan, Junping, He, Xiang, Zhong, Shiqian, Zhang, Rongcai, Choi, LokLam, Su, Weiwei, Chen, Jiaxu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204815/ https://www.ncbi.nlm.nih.gov/pubmed/35657168 http://dx.doi.org/10.1021/acs.jafc.2c02140 |
Ejemplares similares
-
In vitro evaluation of the effect of C-4 substitution on methylation of 7,8-dihydroxycoumarin: metabolic profile and catalytic kinetics
por: Xia, Yang-Liu, et al.
Publicado: (2018) -
7,8-Dihydroxycoumarin inhibits A549 human lung adenocarcinoma cell proliferation by inducing apoptosis via suppression of Akt/NF-κB signaling
por: WANG, YUE, et al.
Publicado: (2013) -
Evaluation of the Biological Activity of Naturally Occurring 5,8-Dihydroxycoumarin
por: Slapšytė, Gražina, et al.
Publicado: (2013) -
TREM2 activation alleviates neural damage via Akt/CREB/BDNF signalling after traumatic brain injury in mice
por: Yan, Jin, et al.
Publicado: (2022) -
Inhibition of Necroptosis Rescues SAH-Induced Synaptic Impairments in Hippocampus via CREB-BDNF Pathway
por: Yang, Chunlei, et al.
Publicado: (2019)